SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0000899243-22-034983
Filing Date
2022-11-03
Accepted
2022-11-03 19:19:20
Documents
2
Period of Report
2022-11-03

Document Format Files

Seq Description Document Type Size
1 FORM 3 SUBMISSION doc3.html 3  
1 FORM 3 SUBMISSION doc3.xml 3 1556
2 EX-24 DOCUMENT attachment1.htm EX-24 4471
  Complete submission text file 0000899243-22-034983.txt   7415
Mailing Address C/O ARRAY BIOPHARMA INC. 3200 WALNUT STREET BOULDER CO 80301
Business Address
Sandor Victor (Reporting) CIK: 0001620368 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-39460 | Film No.: 221359742

Mailing Address 200 ARSENAL YARDS BLVD., SUITE 230 WATERTOWN MA 02472
Business Address 200 ARSENAL YARDS BLVD., SUITE 230 WATERTOWN MA 02472 857-285-5314
Kymera Therapeutics, Inc. (Issuer) CIK: 0001815442 (see all company filings)

IRS No.: 812992166 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)